Number of gastrointestinal disease tests and treatments

Name of test/treatment Fiscal Year 2021 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2024 FY2025
Upper gastrointestinal endoscopy 4,332 3,985 3,693 3,587 3,597
Colonoscopy 1,948 1,946 2,082 2,028 2,163
colorectal polypectomy 174 184 222 189 288
Gastrointestinal endoscopy (including ultrasound endoscopy and balloon dilation) 454 544 535 536 491
Endoscopic submucosal dissection (esophageal ESD) 69 66 71 62 77
Endoscopic submucosal dissection (gastric and duodenal ESD) 103 107 100 107 102
Endoscopic submucosal dissection (colorectal ESD) 40 69 76 65 88
Gastroduodenal endoscopic mucosal resection (EMR) 16 12 22 21 25
Argon plasma coagulation (APC) 3 3 4 4 4
Endoscopic gastrostomy (PEG) 74 73 75 71 45
Capsule Endoscope (CE) 63 37 40 35 26
Double-balloon small bowel endoscopy (DBE) 107 108 120 90 119
　Of which, endoscopic balloon small and large bowel dilatation (EBD) 15 18 16 13 18

Number of pancreaticobiliary diseases examined and treated

Name of test/treatment Fiscal Year 2021 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2024 FY2025
Endoscopic retrograde cholangiopancreatography (ERCP) 284 360 370 489 405
　Of which, emergency ERCP (within 24 hours) 72 94 128 175 124
Endoscopic gastroduodenal stenting 16 9 10 12 18
Double-balloon endoscopic retrograde cholangiopancreatography (DB-ERCP) 12 18 21 33 45
Cholangiopancreatic ultrasound endoscopy (EUS) 252 327 375 396 407
Endoscopic ultrasound-assisted puncture aspiration (EUS-FNA) 144 121 142 143 179
Ultrasound endoscopic drainage (Interventional EUS) 14 11 17 13 14
Peptide receptor radionuclide therapy (PRRT) 1 3 3 10 13

Number of liver disease tests and treatments

Name of test/treatment Fiscal Year 2021 Fiscal Year 2022 Fiscal Year 2023 Fiscal Year 2024 FY2025
abdominal ultrasonography 3,994 3,953 4,020 4,162 4,282
liver biopsy 85 64 62 68 86
Liver tumor biopsy 35 42 60 48 55
Radiofrequency ablation therapy (RFA) 32 25 35 32 61
Sclerotherapy and ligation of esophageal varices (EIS/EVL) 26 26 18 16 11